US Stock MarketDetailed Quotes
TSHA Taysha Gene Therapies
- 2.2000
- -0.0400-1.79%
Close Aug 23 16:00 ET
- 2.2200
- +0.0200+0.91%
Post 20:01 ET
450.88MMarket Cap-4489P/E (TTM)
2.2800High2.1700Low1.15MVolume2.2500Open2.2400Pre Close2.55MTurnover0.94%Turnover RatioLossP/E (Static)204.94MShares4.320052wk High4.14P/B269.02MFloat Cap1.270052wk Low--Dividend TTM122.28MShs Float33.3500Historical High--Div YieldTTM4.91%Amplitude0.5000Historical Low2.2180Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Taysha Gene Therapies Stock Forum
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Taysha Gene Therapies (Nasdaq: TSHA) has announced a public offering of up to $75 million in common stock and pre-funded warrants. This offering allows certain investors the option to purchase pre-funded warrants instead of common stock. Additionally, underwriters Jefferies, Goldman Sachs, and Cantor have a 30-day option to buy up to 15% more shares under the same...
3 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
Company to host webcast on Tuesday, June 18, 2024, at 8:00 AM Eastern Time
Oral presentation by Elsa Rossignol, M.D., FRCP, FAAP, Principal Investigator of the REVEAL adolescent and adult trial at CHU Sainte-Justine and Colleen Buhrf...
Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (Rmat) Designation Granted by U.S. FDA for Tsha-102 in Rett Syndrome
No comment yet